These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14715498)

  • 21. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.
    Pelletier JP; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Di Battista JA; Martel-Pelletier J
    Arthritis Rheum; 1998 Jul; 41(7):1275-86. PubMed ID: 9663486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological characterization of L-N(6)-(1-iminoethyl)lysine 5-tetrazole-amide, a prodrug of a selective iNOS inhibitor.
    Hallinan EA; Tsymbalov S; Dorn CR; Pitzele BS; Hansen DW; Moore WM; Jerome GM; Connor JR; Branson LF; Widomski DL; Zhang Y; Currie MG; Manning PT
    J Med Chem; 2002 Apr; 45(8):1686-9. PubMed ID: 11931623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of inducible nitric oxide synthase inhibitor L-N6-(1-iminoethyl) lysine in gentamicin-induced acute tubular necrosis in rats.
    Avdagić N; Nakas-Ićindić E; Rasić S; Hadzović-Dzuvo A; Zaciragić A; Valjevac A
    Bosn J Basic Med Sci; 2007 Nov; 7(4):345-51. PubMed ID: 18039194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exogenous and endogenous nitric oxide but not iNOS inhibition improves function and survival of ischemically injured livers.
    Rivera-Chavez FA; Toledo-Pereyra LH; Dean RE; Crouch L; Ward PA
    J Invest Surg; 2001; 14(5):267-73. PubMed ID: 11700920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.
    Reilly CM; Farrelly LW; Viti D; Redmond ST; Hutchison F; Ruiz P; Manning P; Connor J; Gilkeson GS
    Kidney Int; 2002 Mar; 61(3):839-46. PubMed ID: 11849435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-dependent aggravation or attenuation of lipopolysaccharide-induced gastric injury by nitric oxide synthase inhibition.
    Suliburk JW; Helmer KS; Kennison SD; Mercer DW; Robinson EK
    J Surg Res; 2005 Dec; 129(2):265-71. PubMed ID: 16026802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
    Handy RL; Moore PK
    Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of L-N6-(1-iminoethyl)-lysine, an inducible nitric oxide synthase inhibitor, on murine immune response induced by Actinobacillus actinomycetemcomitans lipopolysaccharide.
    Sosroseno W; Musa M; Ravichandran M; Fikri Ibrahim M; Bird PS; Seymour GJ
    J Periodontal Res; 2007 Apr; 42(2):124-30. PubMed ID: 17305870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of inducible nitric oxide synthase in persistent pain.
    Budziñski M; Misterek K; Gumulka W; Dorociak A
    Life Sci; 2000; 66(4):301-5. PubMed ID: 10665981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects of noradrenaline in hypovolemic haemorrhage: role of inducible nitric oxide synthase.
    Tabrizchi R
    Eur J Pharmacol; 1998 Nov; 361(2-3):227-34. PubMed ID: 9865512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of hypoxic pulmonary vasoconstriction is time and nitric oxide dependent in a peritonitis model of sepsis.
    Fischer LG; Freise H; Hilpert JH; Wendholt D; Lauer S; Van Aken H; Sielenkämper AW
    Intensive Care Med; 2004 Sep; 30(9):1821-8. PubMed ID: 15375651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia.
    Matejovic M; Krouzecky A; Martinkova V; Rokyta R; Kralova H; Treska V; Radermacher P; Novak I
    Shock; 2004 May; 21(5):458-65. PubMed ID: 15087823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary nitrate excretion in cholesterol-fed rabbits: effect of a chronic treatment by N-iminoethyl-L-lysine, a selective inhibitor of inducible nitric oxide synthase.
    Behr-Roussel D; Rupin A; Simonet S; Fabiani J; Verbeuren TJ
    Eur J Pharmacol; 2000 Feb; 388(3):275-9. PubMed ID: 10675737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine.
    Wolff DJ; Lubeskie A; Gauld DS; Neulander MJ
    Eur J Pharmacol; 1998 Jun; 350(2-3):325-34. PubMed ID: 9696424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
    Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P
    Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant treatment inhibits activation of myocardial nuclear factor kappa B and inhibits nitrosylation of myocardial heme protein in cardiac transplant rejection.
    Pieper GM; Olds C; Hilton G; Lindholm PF; Adams MB; Roza AM
    Antioxid Redox Signal; 2001 Feb; 3(1):81-8. PubMed ID: 11291601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GW274150 inhibits nitric oxide production by primary cultures of rat proximal tubular cells.
    Chatterjee PK; Kvale EO; Patel NS; Thiemermann C
    Med Sci Monit; 2003 Oct; 9(10):BR357-62. PubMed ID: 14523323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of inducible nitric oxide synthase results in reductions in wound vascular endothelial growth factor expression, granulation tissue formation, and local perfusion.
    Howdieshell TR; Webb WL; Sathyanarayana ; McNeil PL
    Surgery; 2003 May; 133(5):528-37. PubMed ID: 12773981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase.
    Moore WM; Webber RK; Jerome GM; Tjoeng FS; Misko TP; Currie MG
    J Med Chem; 1994 Nov; 37(23):3886-8. PubMed ID: 7525961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits.
    Behr-Roussel D; Rupin A; Simonet S; Bonhomme E; Coumailleau S; Cordi A; Serkiz B; Fabiani JN; Verbeuren TJ
    Circulation; 2000 Aug; 102(9):1033-8. PubMed ID: 10961969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.